DK1658365T3 - Fremgangsmåde til genkloning af produktionsceller - Google Patents
Fremgangsmåde til genkloning af produktionscellerInfo
- Publication number
- DK1658365T3 DK1658365T3 DK04764194T DK04764194T DK1658365T3 DK 1658365 T3 DK1658365 T3 DK 1658365T3 DK 04764194 T DK04764194 T DK 04764194T DK 04764194 T DK04764194 T DK 04764194T DK 1658365 T3 DK1658365 T3 DK 1658365T3
- Authority
- DK
- Denmark
- Prior art keywords
- gene cloning
- production cells
- cells
- production
- cloning
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
- C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10338531A DE10338531A1 (de) | 2003-08-19 | 2003-08-19 | Verfahren zur Reklonierung von Produktionszellen |
| PCT/EP2004/009204 WO2005019442A2 (de) | 2003-08-19 | 2004-08-17 | Verfahren zur reklonierung von produktionszellen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1658365T3 true DK1658365T3 (da) | 2009-02-02 |
Family
ID=34201814
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04764194T DK1658365T3 (da) | 2003-08-19 | 2004-08-17 | Fremgangsmåde til genkloning af produktionsceller |
| DK08151018.2T DK1918364T3 (da) | 2003-08-19 | 2004-08-17 | Fremgangsmåde til rekloning af produktionsceller |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08151018.2T DK1918364T3 (da) | 2003-08-19 | 2004-08-17 | Fremgangsmåde til rekloning af produktionsceller |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7833787B2 (https=) |
| EP (2) | EP1918364B1 (https=) |
| JP (1) | JP5129959B2 (https=) |
| KR (1) | KR101184572B1 (https=) |
| AT (2) | ATE415471T1 (https=) |
| CA (1) | CA2536239C (https=) |
| DE (2) | DE10338531A1 (https=) |
| DK (2) | DK1658365T3 (https=) |
| ES (2) | ES2368772T3 (https=) |
| TW (1) | TWI337201B (https=) |
| WO (1) | WO2005019442A2 (https=) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223183A1 (en) * | 2005-03-11 | 2006-10-05 | Bates Steven E | Gamma irradiation of frozen feeder cells |
| EP1901068A1 (en) * | 2006-09-15 | 2008-03-19 | Boehringer Ingelheim Pharma GmbH & Co. KG | Methods of selecting cell clones |
| EP2067038A1 (en) * | 2006-09-15 | 2009-06-10 | Boehringer Ingelheim Pharma GmbH & Co. KG | Methods of selecting cell clones |
| EP2257620A1 (de) * | 2008-03-19 | 2010-12-08 | Boehringer Ingelheim Pharma GmbH & Co. KG | Methode zur steigerung der reklonierungseffizienz |
| JP5304275B2 (ja) * | 2009-01-29 | 2013-10-02 | Ｊｎｃ株式会社 | アポクライティン−ｉｉをコードするコドン最適化核酸およびその使用方法 |
| EP2417248B1 (en) | 2009-04-09 | 2019-05-22 | Sartorius Stedim Cellca GmbH | Method for improved single cell cloning |
| CA2781332C (en) * | 2009-11-19 | 2018-09-04 | National University Corporation Okayama University | System for increasing gene expression and vector comprising the system |
| RS63930B1 (sr) | 2011-10-28 | 2023-02-28 | Prothena Biosciences Ltd | Humanizovana antitela koja prepoznaju alfa-sinuklein |
| DK2807188T3 (da) | 2012-01-27 | 2019-10-07 | Prothena Biosciences Ltd | Humaniserede antistoffer, der genkender alpha-synuclein |
| UA118441C2 (uk) | 2012-10-08 | 2019-01-25 | Протена Біосаєнсиз Лімітед | Антитіло, що розпізнає альфа-синуклеїн |
| US10501531B2 (en) | 2013-03-13 | 2019-12-10 | Prothena Biosciences Limited | Tau immunotherapy |
| US10513555B2 (en) | 2013-07-04 | 2019-12-24 | Prothena Biosciences Limited | Antibody formulations and methods |
| US9850302B2 (en) | 2013-07-12 | 2017-12-26 | Prothena Biosciences Limited | Antibodies that recognize IAPP |
| WO2015004633A1 (en) | 2013-07-12 | 2015-01-15 | Neotope Biosciences Limited | Antibodies that recognize islet-amyloid polypeptide (iapp) |
| JP2017501848A (ja) | 2013-11-19 | 2017-01-19 | プロセナ バイオサイエンシーズ リミテッド | 便秘症状からのレビー小体病の免疫療法のモニター |
| KR20160131082A (ko) | 2014-03-12 | 2016-11-15 | 프로테나 바이오사이언시즈 리미티드 | Lg1-3에 특이적인 항-라미닌4 항체 |
| PT3116911T (pt) | 2014-03-12 | 2019-09-04 | Prothena Biosciences Ltd | Anticorpos anti-mcam e métodos de utilização associados |
| TW201623331A (zh) | 2014-03-12 | 2016-07-01 | 普羅帝納生物科學公司 | 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法 |
| JP2017514458A (ja) | 2014-03-12 | 2017-06-08 | プロセナ バイオサイエンシーズ リミテッド | Ｌｇ４−５に対して特異的な抗−ラミニン４抗体 |
| CA2944402A1 (en) | 2014-04-08 | 2015-10-15 | Prothena Biosciences Limited | Blood-brain barrier shuttles containing antibodies recognizing alpha-synuclein |
| TWI786505B (zh) | 2015-01-28 | 2022-12-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| TWI718121B (zh) | 2015-01-28 | 2021-02-11 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| TWI769570B (zh) | 2015-01-28 | 2022-07-01 | 愛爾蘭商普羅佘納生物科技有限公司 | 抗甲狀腺素運送蛋白抗體 |
| WO2017046774A2 (en) | 2015-09-16 | 2017-03-23 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| EP3350226A2 (en) | 2015-09-16 | 2018-07-25 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of giant cell arteritis, polymyalgia rheumatica or takayasu's arteritis |
| WO2017149513A1 (en) | 2016-03-03 | 2017-09-08 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| WO2017153953A1 (en) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases |
| WO2017153955A1 (en) | 2016-03-09 | 2017-09-14 | Prothena Biosciences Limited | Use of anti-mcam antibodies for treatment or prophylaxis of granulomatous lung diseases |
| MX2018013386A (es) | 2016-05-02 | 2019-02-28 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau. |
| MY198194A (en) | 2016-05-02 | 2023-08-09 | Prothena Biosciences Ltd | Antibodies Recognizing Tau |
| PT3452507T (pt) | 2016-05-02 | 2022-12-20 | Prothena Biosciences Ltd | Imunoterapia anti-tau |
| WO2017208210A1 (en) | 2016-06-03 | 2017-12-07 | Prothena Biosciences Limited | Anti-mcam antibodies and associated methods of use |
| WO2018007922A2 (en) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| WO2018007924A2 (en) | 2016-07-02 | 2018-01-11 | Prothena Biosciences Limited | Anti-transthyretin antibodies |
| JP7016470B2 (ja) | 2016-07-02 | 2022-02-07 | プロセナ バイオサイエンシーズ リミテッド | 抗トランスサイレチン抗体 |
| KR102784294B1 (ko) | 2017-05-02 | 2025-03-19 | 프로테나 바이오사이언시즈 리미티드 | 타우 인식 항체 |
| WO2019064053A1 (en) | 2017-09-28 | 2019-04-04 | Prothena Biosciences Limited | DOSAGE REGIMES FOR THE TREATMENT OF SYNUCLEINOPATHIES |
| AU2018345807B2 (en) | 2017-10-06 | 2025-02-06 | Novo Nordisk A/S | Methods of detecting transthyretin |
| PE20211453A1 (es) | 2017-11-29 | 2021-08-05 | Prothena Biosciences Ltd | Formulacion liofilizada de un anticuerpo monoclonal contra transtirretina |
| CU24781B1 (es) | 2018-11-08 | 2026-02-09 | Prothena Biosciences Ltd | Anticuerpos humanizados que reconocen tau |
| EA202190986A1 (ru) | 2018-11-26 | 2021-12-14 | Фоти Севен, Инк. | ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА К c-Kit |
| JP7630834B2 (ja) | 2019-03-03 | 2025-02-18 | プロセナ バイオサイエンシーズ リミテッド | タウ認識抗体 |
| BR112022026508A2 (pt) | 2020-06-24 | 2023-03-07 | Prothena Biosciences Ltd | Anticorpos que reconhecem sortilina |
| WO2025059486A1 (en) | 2023-09-15 | 2025-03-20 | Prothena Biosciences Limited | Anti-tdp-43 antibodies and uses thereof |
| WO2025059491A2 (en) | 2023-09-15 | 2025-03-20 | Prothena Platform Technologies Limited | Methods, compositions, and kits including cell-penetrating agents |
| AR133834A1 (es) | 2023-09-15 | 2025-11-05 | Prothena Biosciences Ltd | Agentes de penetración célular y sus usos |
| TW202530246A (zh) | 2023-09-15 | 2025-08-01 | 愛爾蘭商歐賽爾普羅希那有限公司 | 細胞穿透劑及其用途 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
| US5008198A (en) | 1984-09-14 | 1991-04-16 | Scripps Clinic And Research Foundation | Merozoite surface glycoproteins |
| IE913929A1 (en) | 1990-11-13 | 1992-05-20 | Immunex Corp | Bifunctional selectable fusion genes |
| US5459058A (en) * | 1991-03-28 | 1995-10-17 | Benjamin Rich | Cell culture system |
| AU6953394A (en) | 1993-05-21 | 1994-12-20 | Targeted Genetics Corporation | Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
| DE19539493A1 (de) | 1995-10-24 | 1997-04-30 | Thomae Gmbh Dr K | Starker homologer Promotor aus Hamster |
| ES2226383T3 (es) | 1998-04-17 | 2005-03-16 | Societe Des Produits Nestle S.A. | Linea de celulas inmortalizadas derivadas de tejidos cutaneos humanos normales. |
| WO2000034318A1 (en) | 1998-12-11 | 2000-06-15 | Clontech Laboratories, Inc. | Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| WO2000034319A1 (en) | 1998-12-11 | 2000-06-15 | Clontech Laboratories, Inc. | Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| WO2000034326A1 (en) | 1998-12-11 | 2000-06-15 | Clontech Laboratories, Inc. | Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof |
| ES2257303T3 (es) | 1999-07-12 | 2006-08-01 | Genentech, Inc. | Vectores de expresion y procedimientos. |
| DK1200561T3 (da) * | 1999-08-05 | 2006-10-16 | Baxter Ag | Rekombinant stabil celleklon, dens fremstilling og anvendelse |
| US7456017B2 (en) * | 1999-10-01 | 2008-11-25 | University Of North Carolina At Chapel Hill | Processes for clonal growth of hepatic progenitor cells |
| JP2003527833A (ja) | 1999-10-14 | 2003-09-24 | クロンテック・ラボラトリーズ・インコーポレーテッド | 花虫類に由来する発色団／蛍光体、およびそれらの使用法 |
| CN1461341A (zh) * | 2000-10-03 | 2003-12-10 | 北卡罗来纳大学 | 肝祖先细胞克隆生长的方法 |
| US20030073234A1 (en) * | 2001-10-12 | 2003-04-17 | Michal Amit | Clonal human embryonic stem cell lines and methods of generating same |
-
2003
- 2003-08-19 DE DE10338531A patent/DE10338531A1/de not_active Ceased
-
2004
- 2004-08-17 EP EP08151018A patent/EP1918364B1/de not_active Expired - Lifetime
- 2004-08-17 AT AT04764194T patent/ATE415471T1/de active
- 2004-08-17 DK DK04764194T patent/DK1658365T3/da active
- 2004-08-17 WO PCT/EP2004/009204 patent/WO2005019442A2/de not_active Ceased
- 2004-08-17 DK DK08151018.2T patent/DK1918364T3/da active
- 2004-08-17 DE DE502004008542T patent/DE502004008542D1/de not_active Expired - Lifetime
- 2004-08-17 ES ES08151018T patent/ES2368772T3/es not_active Expired - Lifetime
- 2004-08-17 CA CA2536239A patent/CA2536239C/en not_active Expired - Fee Related
- 2004-08-17 ES ES04764194T patent/ES2317023T3/es not_active Expired - Lifetime
- 2004-08-17 JP JP2006523593A patent/JP5129959B2/ja not_active Expired - Fee Related
- 2004-08-17 KR KR1020067003371A patent/KR101184572B1/ko not_active Expired - Fee Related
- 2004-08-17 AT AT08151018T patent/ATE515565T1/de active
- 2004-08-17 EP EP04764194A patent/EP1658365B1/de not_active Expired - Lifetime
- 2004-08-18 TW TW093124872A patent/TWI337201B/zh not_active IP Right Cessation
- 2004-08-19 US US10/922,577 patent/US7833787B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2368772T3 (es) | 2011-11-22 |
| ATE515565T1 (de) | 2011-07-15 |
| US20050059146A1 (en) | 2005-03-17 |
| ES2317023T3 (es) | 2009-04-16 |
| CA2536239C (en) | 2014-05-27 |
| DE502004008542D1 (de) | 2009-01-08 |
| WO2005019442A2 (de) | 2005-03-03 |
| KR101184572B1 (ko) | 2012-09-21 |
| ATE415471T1 (de) | 2008-12-15 |
| WO2005019442A3 (de) | 2005-10-06 |
| DK1918364T3 (da) | 2011-08-29 |
| EP1918364A3 (de) | 2008-05-14 |
| DE10338531A1 (de) | 2005-04-07 |
| US7833787B2 (en) | 2010-11-16 |
| EP1658365B1 (de) | 2008-11-26 |
| JP5129959B2 (ja) | 2013-01-30 |
| KR20060065706A (ko) | 2006-06-14 |
| EP1918364A2 (de) | 2008-05-07 |
| EP1918364B1 (de) | 2011-07-06 |
| TW200516148A (en) | 2005-05-16 |
| CA2536239A1 (en) | 2005-03-03 |
| EP1658365A2 (de) | 2006-05-24 |
| TWI337201B (en) | 2011-02-11 |
| JP2007502608A (ja) | 2007-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1658365T3 (da) | Fremgangsmåde til genkloning af produktionsceller | |
| DK2152892T3 (da) | Fremgangsmåde til indføring af nukleinsyrer i fungale celler | |
| DK2959774T3 (da) | Fremgangsmåde til kryokonservering af sædceller | |
| DK2058243T3 (da) | Fremgangsmåde til fremstilling af drikke | |
| IS7992A (is) | Dýralaus frumuræktunar aðferð | |
| DK1807673T3 (da) | Fremgangsmåde til fremstilling af sporbar ammunition | |
| DK1745136T3 (da) | Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK1467993T3 (da) | Fremgangsmåde til fremstilling af scopinestere | |
| DK1585630T3 (da) | Fremgangsmåde til ekstraktion af kontaktlinser | |
| DK2080808T3 (da) | Fremgangsmåde til fremstilling af l-aminosyre | |
| DE602005026757D1 (de) | Tonerherstellungsmethode | |
| NO20033110L (no) | Fremgangsmate for fremstilling av gassdiffusjonselektroder | |
| DK1480491T3 (da) | Tynd højttaler samt fremgangsmåde til fremstilling deraf | |
| DK1825484T3 (da) | Fremgangsmåde til fremstilling af kabler | |
| PL394821A1 (pl) | Sposób wytwarzania kombrestatyn | |
| IS8416A (is) | Aðferð við framleiðslu á CCR-2 mótlyfi | |
| EP1848843A4 (en) | METHOD FOR MANUFACTURING SILICON INGOTS WITH DIRECTIONAL SOLIDIFICATION | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DE602004003115D1 (de) | Tonerherstellungsverfahren | |
| ATE465155T1 (de) | Verfahrensherstellung von ethern | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| IS8646A (is) | Aðferð til að framleiða spendýrafrumur | |
| DK1805316T3 (da) | Fremgangsmåde til fremstilling af de enantiomere former af cis-3-hydroxycy- |